COST PLUS DRUG holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 9 (Electronics & Software) with 1 filings. The WikiTrademarks Expansion Score is 1/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed July 31, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is COST PLUS DRUG filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 97233172 | COST PLUS DRUG | Jan 22, 2022 | Registered | 009 Electronics & Software | NFT Technology Inc |
Weekly visibility reports showing how ChatGPT mentions COST PLUS DRUG, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: COST PLUS DRUG trademark portfolio
What trademarks does COST PLUS DRUG hold?
COST PLUS DRUG holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 9 (Electronics & Software). The most recent filings are registered to NFT Technology Inc.
How many trademarks does COST PLUS DRUG have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to COST PLUS DRUG. The brand has been actively filing since January 2022. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does COST PLUS DRUG file most often?
COST PLUS DRUG's most active class is NICE Class 9 (Electronics & Software), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the COST PLUS DRUG trademark?
The most recent filings under the COST PLUS DRUG mark are registered to NFT Technology Inc. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is COST PLUS DRUG expanding into new categories?
The current WikiTrademarks Expansion Score for COST PLUS DRUG is 1 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new COST PLUS DRUG trademark filings?
Click the Watch Brand button at the top of this page to add COST PLUS DRUG to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare COST PLUS DRUG to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about COST PLUS DRUG and help the next person researching it.